On December 10, 2024, CVS Health Corporation issued $3 billion in junior subordinated notes. The offering comprised $2.25 billion of 7.000% Fixed-to-Fixed Rate Series A Junior Subordinated Notes due 2055 and $750 million of 6.750% Fixed-to-Fixed Rate Series B Junior Subordinated Notes due 2054.The notes were offered under CVS Health's Registration Statement on Form S-3ASR, filed on May 25, 2023. They are governed by a Subordinated Indenture dated May 25, 2007, as supplemented by the Second and Third Supplemental Indentures dated December 10, 2024. The company may issue additional subordinated debt securities under the Base Indenture in the future.

On December 10, 2024, CVS Health Corporation issued $3 billion in junior subordinated notes. The offering comprised $2.25 billion of 7.000% Fixed-to-Fixed Rate Series A Junior Subordinated Notes due 2055 and $750 million of 6.750% Fixed-to-Fixed Rate Series B Junior Subordinated Notes due 2054.The notes were offered under CVS Health's Registration Statement on Form S-3ASR, filed on May 25, 2023. They are governed by a Subordinated Indenture dated May 25, 2007, as supplemented by the Second and Third Supplemental Indentures dated December 10, 2024. The company may issue additional subordinated debt securities under the Base Indenture in the future.